These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38657592)

  • 1. Cassia angustifolia and tacrolimus interaction in a liver transplant patient, a case report.
    Beltrá-Picó I; Díaz-González M; Nalda-Molina R; Ramon-Lopez A; Pascual-Bartolomé S; Miralles-Macià CF; Rodríguez-Soler M; Más-Serrano P
    Br J Clin Pharmacol; 2024 Jul; 90(7):1745-1750. PubMed ID: 38657592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
    Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
    Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Factors Affecting Tacrolimus Trough Levels in Latin American Pediatric Liver Transplant Patients.
    Riva N; Woillard JB; Distefano M; Moragas M; Dip M; Halac E; Cáceres Guido P; Licciardone N; Mangano A; Bosaleh A; de Davila MT; Schaiquevich P; Imventarza O
    Liver Transpl; 2019 Sep; 25(9):1397-1407. PubMed ID: 31102573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Schisandra sphenanthera extract on the concentration of tacrolimus in the blood of liver transplant patients.
    Jiang W; Wang X; Xu X; Kong L
    Int J Clin Pharmacol Ther; 2010 Mar; 48(3):224-9. PubMed ID: 20197017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2004; 43(10):623-53. PubMed ID: 15244495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration.
    McAlister VC; Mahalati K; Peltekian KM; Fraser A; MacDonald AS
    Ther Drug Monit; 2002 Jun; 24(3):346-50. PubMed ID: 12021624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients.
    Pea F; Tavio M; Pavan F; Londero A; Bresadola V; Adani GL; Furlanut M; Viale P
    Antivir Ther; 2008; 13(5):739-42. PubMed ID: 18771060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation.
    Anglicheau D; Flamant M; Schlageter MH; Martinez F; Cassinat B; Beaune P; Legendre C; Thervet E
    Nephrol Dial Transplant; 2003 Nov; 18(11):2409-14. PubMed ID: 14551375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients.
    Dansirikul C; Staatz CE; Duffull SB; Taylor PJ; Lynch SV; Tett SE
    J Clin Pharm Ther; 2006 Feb; 31(1):17-25. PubMed ID: 16476116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
    Nashan B; Saliba F; Durand F; Barcéna R; Herrero JI; Mentha G; Neuhaus P; Bowles M; Patch D; Bernardos A; Klempnauer J; Bouw R; Ives J; Mamelok R; McKay D; Truman M; Marotta P
    Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings.
    Zucker K; Rosen A; Tsaroucha A; de Faria L; Roth D; Ciancio G; Esquenazi V; Burke G; Tzakis A; Miller J
    Transpl Immunol; 1997 Sep; 5(3):225-32. PubMed ID: 9402690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of oral versus sublingual administration of tacrolimus in adult liver transplant recipients.
    Nasiri-Toosi Z; Dashti-Khavidaki S; Nasiri-Toosi M; Khalili H; Jafarian A; Irajian H; Abdollahi A; Sadrai S
    Exp Clin Transplant; 2012 Dec; 10(6):586-91. PubMed ID: 22770208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the most influential sources of variability in tacrolimus trough blood concentrations in adult liver transplant recipients: a bottom-up approach.
    Gérard C; Stocco J; Hulin A; Blanchet B; Verstuyft C; Durand F; Conti F; Duvoux C; Tod M
    AAPS J; 2014 May; 16(3):379-91. PubMed ID: 24526611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label investigation into drug-drug interactions between multiple doses of daclatasvir and single-dose cyclosporine or tacrolimus in healthy subjects.
    Bifano M; Adamczyk R; Hwang C; Kandoussi H; Marion A; Bertz RJ
    Clin Drug Investig; 2015 May; 35(5):281-9. PubMed ID: 25896946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients.
    Shi Y; Li Y; Tang J; Zhang J; Zou Y; Cai B; Wang L
    Gene; 2013 Jan; 512(2):226-31. PubMed ID: 23107770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower tacrolimus trough levels in the late period after living donor liver transplantation contribute to improvements in long-term clinical outcomes.
    Geng L; Wang LD; Huang JJ; Shen T; Wang ZY; Lin BY; Ye YF; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):204-209. PubMed ID: 29807766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of tacrolimus exposure on extrarenal adverse effects in adult renal transplant recipients.
    Campagne O; Mager DE; Brazeau D; Venuto RC; Tornatore KM
    Br J Clin Pharmacol; 2019 Mar; 85(3):516-529. PubMed ID: 30414331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interaction between tacrolimus and diltiazem: dose-response relationship in kidney and liver transplant recipients.
    Jones TE; Morris RG
    Clin Pharmacokinet; 2002; 41(5):381-8. PubMed ID: 12036394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal vein thrombosis related to Cassia angustifolia.
    Soyuncu S; Cete Y; Nokay AE
    Clin Toxicol (Phila); 2008 Sep; 46(8):774-7. PubMed ID: 19238740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.